Pharvaris
Pharvaris is a biopharmaceutical company developing oral therapies for hereditary angioedema. They are expanding their U.S. Commercial team and seeking a National Account Director to drive market access and payer relationships. The role involves collaboration across functions to ensure treatment coverage and reimbursement for their innovative products.
Pharvaris is a late-stage biopharmaceutical company focused on hereditary angioedema (HAE). It develops novel, oral bradykinin B2 receptor antagonists designed to treat and prevent HAE attacks, aiming to broaden therapeutic options beyond injectable therapies. Guided by the tagline "Pioneering Science for Patient Choice," Pharvaris advances clinical-stage small-molecule programs to deliver more convenient, patient-centered treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pharvaris.
80% above the average for this role
National Account Director, Payer Accounts
Zenas BioPharma
National Account Executive
Genetix Biotherapeutics
National Account Director, United/Optum
Intellia Therapeutics
National Account Executive
Genetix Biotherapeutics
National Strategic Account Executive
CG Oncology
Senior Manager, Payer Marketing, Rare Disease (Remote)
Amgen